Search Results - PROMIS Investigators, Group

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract P2-14-11: Treatment recommendations in ER+ patients ≤ 50 years: Comparison of the 21-gene assay and 70-gene signature in the PROMIS study

    Abstract P2-14-11: Treatment recommendations in ER+ patients ≤ 50 years: Comparison of the 21-gene assay and 70-gene signature in the PROMIS study by Tsai, Michaela, Soliman, Hatem, Lo, Shelly, Qamar, Rubina, Budway, Raye, Levine, Ellis, Whitworth, Pat, Mavromatis, Blanche, Zon, Robin, Untch, Sarah, Blumencranz, Lisa, McKelley, Joseph, Audeh, William

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P4-08-10: MammaPrint identifies 46% of patients, age ≤50 years with oncotype RS 18-30, as low risk and safe to forgo chemotherapy

    Abstract P4-08-10: MammaPrint identifies 46% of patients, age ≤50 years with oncotype RS 18-30, as low risk and safe to forgo chemotherapy by Soliman, H, Lo, S, Qamar, R, Budway, R, Levine, E, Whitworth, P, Mavromatis, B, Zon, R, Untch, S, Treece, T, Blumencranz, L, Audeh, W, Tsai, M, PROMIS Investigators, Group

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: